191 related articles for article (PubMed ID: 9852148)
1. Two functional states of the CD11b A-domain: correlations with key features of two Mn2+-complexed crystal structures.
Li R; Rieu P; Griffith DL; Scott D; Arnaout MA
J Cell Biol; 1998 Dec; 143(6):1523-34. PubMed ID: 9852148
[TBL] [Abstract][Full Text] [Related]
2. Solvent-accessible residues on the metal ion-dependent adhesion site face of integrin CR3 mediate its binding to the neutrophil inhibitory factor.
Rieu P; Sugimori T; Griffith DL; Arnaout MA
J Biol Chem; 1996 Jul; 271(27):15858-61. PubMed ID: 8663417
[TBL] [Abstract][Full Text] [Related]
3. Cation binding to the integrin CD11b I domain and activation model assessment.
Baldwin ET; Sarver RW; Bryant GL; Curry KA; Fairbanks MB; Finzel BC; Garlick RL; Heinrikson RL; Horton NC; Kelley LL; Mildner AM; Moon JB; Mott JE; Mutchler VT; Tomich CS; Watenpaugh KD; Wiley VH
Structure; 1998 Jul; 6(7):923-35. PubMed ID: 9687375
[TBL] [Abstract][Full Text] [Related]
4. Conformational changes in tertiary structure near the ligand binding site of an integrin I domain.
Oxvig C; Lu C; Springer TA
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2215-20. PubMed ID: 10051621
[TBL] [Abstract][Full Text] [Related]
5. NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding.
Huth JR; Olejniczak ET; Mendoza R; Liang H; Harris EA; Lupher ML; Wilson AE; Fesik SW; Staunton DE
Proc Natl Acad Sci U S A; 2000 May; 97(10):5231-6. PubMed ID: 10805782
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a conformationally sensitive murine monoclonal antibody directed to the metal ion-dependent adhesion site face of integrin CD11b.
Li R; Haruta I; Rieu P; Sugimori T; Xiong JP; Arnaout MA
J Immunol; 2002 Feb; 168(3):1219-25. PubMed ID: 11801658
[TBL] [Abstract][Full Text] [Related]
7. Mutagenesis of the Arg-Gly-Asp triplet in human complement component C3 does not abolish binding of iC3b to the leukocyte integrin complement receptor type III (CR3, CD11b/CD18).
Taniguchi-Sidle A; Isenman DE
J Biol Chem; 1992 Jan; 267(1):635-43. PubMed ID: 1730624
[TBL] [Abstract][Full Text] [Related]
8. Two conformations of the integrin A-domain (I-domain): a pathway for activation?
Lee JO; Bankston LA; Arnaout MA; Liddington RC
Structure; 1995 Dec; 3(12):1333-40. PubMed ID: 8747460
[TBL] [Abstract][Full Text] [Related]
9. AlphaMbeta2 (CD11b/CD18, Mac-1) integrin activation by a unique monoclonal antibody to alphaM I domain that is divalent cation-sensitive.
Orchekowski RP; Plescia J; Altieri DC; Bajt ML
J Leukoc Biol; 2000 Nov; 68(5):641-9. PubMed ID: 11073102
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of the leukocyte integrin Mac-1 I-domain interactions with the platelet glycoprotein Ib.
Morgan J; Saleem M; Ng R; Armstrong C; Wong SS; Caulton SG; Fickling A; Williams HEL; Munday AD; López JA; Searle MS; Emsley J
Blood Adv; 2019 May; 3(9):1450-1459. PubMed ID: 31053572
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18).
Lee JO; Rieu P; Arnaout MA; Liddington R
Cell; 1995 Feb; 80(4):631-8. PubMed ID: 7867070
[TBL] [Abstract][Full Text] [Related]
12. A novel divalent cation-binding site in the A domain of the beta 2 integrin CR3 (CD11b/CD18) is essential for ligand binding.
Michishita M; Videm V; Arnaout MA
Cell; 1993 Mar; 72(6):857-67. PubMed ID: 8458080
[TBL] [Abstract][Full Text] [Related]
13. An isoleucine-based allosteric switch controls affinity and shape shifting in integrin CD11b A-domain.
Xiong JP; Li R; Essafi M; Stehle T; Arnaout MA
J Biol Chem; 2000 Dec; 275(49):38762-7. PubMed ID: 11034990
[TBL] [Abstract][Full Text] [Related]
14. The beta-tail domain (betaTD) regulates physiologic ligand binding to integrin CD11b/CD18.
Gupta V; Gylling A; Alonso JL; Sugimori T; Ianakiev P; Xiong JP; Arnaout MA
Blood; 2007 Apr; 109(8):3513-20. PubMed ID: 17170130
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18).
Thornton BP; Vĕtvicka V; Pitman M; Goldman RC; Ross GD
J Immunol; 1996 Feb; 156(3):1235-46. PubMed ID: 8558003
[TBL] [Abstract][Full Text] [Related]
16. Distinct ligand binding sites in the I domain of integrin alpha M beta 2 that differentially affect a divalent cation-dependent conformation.
McGuire SL; Bajt ML
J Biol Chem; 1995 Oct; 270(43):25866-71. PubMed ID: 7592772
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of cation binding to the I domains of LFA-1 and MAC-1. The LFA-1 I domain contains a Ca2+-binding site.
Griggs DW; Schmidt CM; Carron CP
J Biol Chem; 1998 Aug; 273(34):22113-9. PubMed ID: 9705356
[TBL] [Abstract][Full Text] [Related]
18. Structural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3.
Bajic G; Yatime L; Sim RB; Vorup-Jensen T; Andersen GR
Proc Natl Acad Sci U S A; 2013 Oct; 110(41):16426-31. PubMed ID: 24065820
[TBL] [Abstract][Full Text] [Related]
19. Amino acid sequences within the alpha subunit of integrin alpha M beta 2 (Mac-1) critical for specific recognition of C3bi.
Zhang L; Plow EF
Biochemistry; 1999 Jun; 38(25):8064-71. PubMed ID: 10387051
[TBL] [Abstract][Full Text] [Related]
20. The crystal structure of iC3b-CR3 αI reveals a modular recognition of the main opsonin iC3b by the CR3 integrin receptor.
Fernández FJ; Santos-López J; Martínez-Barricarte R; Querol-García J; Martín-Merinero H; Navas-Yuste S; Savko M; Shepard WE; Rodríguez de Córdoba S; Vega MC
Nat Commun; 2022 Apr; 13(1):1955. PubMed ID: 35413960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
